Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Lynne, Strasfeld"'
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
An epidemiological study uncovered that fluoroquinolone (FQ) neutropenic prophylaxis in hematopoietic cell transplant and hematologic malignancy (HCT/HM) patients was associated with breakthrough Pseudomonas aeruginosa bloodstream infections (BSIs) w
Externí odkaz:
https://doaj.org/article/1650b4f4d4794d6cae1cadda9be951ed
Publikováno v:
Blood Advances.
Publikováno v:
Transplant Infectious Disease.
Autor:
Lynne Strasfeld
Publikováno v:
Best practiceresearch. Clinical haematology. 35(3)
HSCT recipients are at increased risk for COVID-19-associated morbidity and mortality. Early treatment of symptomatic SARS-CoV-2 infection is an important means to decreasing risk for severe disease and death. While some HSCT recipients, particularly
Autor:
Andrea J Zimmer, Erica Stohs, Jane Meza, Christopher Arnold, John W Baddley, Pranatharthi Chandrasekar, Zeinab El Boghdadly, Carlos A Gomez, Eileen K Maziarz, Jose G Montoya, Steven Pergam, Kenneth V Rolston, Michael J Satlin, Gowri Satyanarayana, Shmuel Shoham, Lynne Strasfeld, Randy Taplitz, Thomas J Walsh, Jo-Anne H Young, Yuning Zhang, Alison G Freifeld
Publikováno v:
Open forum infectious diseases. 9(7)
Background Rising antimicrobial resistance rates may impact the efficacy of empirical antibiotic treatment for febrile neutropenia in high-risk cancer patients. Lacking contemporary data about the epidemiology, antibiotic resistance patterns, and cli
Publikováno v:
Bone Marrow Transplantation. 56:282-284
Autor:
James S. Lewis, Lynne Strasfeld, David S. Perlin, Brie N. Noble, Lauren Fontana, Yanan Zhao, Morgan Hakki
Publikováno v:
Clin Infect Dis
Background Isavuconazole (ISA) is an attractive candidate for primary mold-active prophylaxis in high-risk patients with hematologic malignancies or hematopoietic cell transplant (HCT) recipients. However, data supporting the use of ISA for primary p
Autor:
Lynne Strasfeld, Lauren Fontana
Publikováno v:
Infectious Disease Clinics of North America
Respiratory virus infections in hematologic stem cell transplant recipients and patients with hematologic malignancies are increasingly recognized as a cause of significant morbidity and mortality. The often overlapping clinical presentation makes mo
Autor:
Lynne Strasfeld, Marcie Riches
Publikováno v:
Blood and Marrow Transplant Handbook ISBN: 9783030536251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9732d452e8f00c837641bfd8d560d37
https://doi.org/10.1007/978-3-030-53626-8_30
https://doi.org/10.1007/978-3-030-53626-8_30
Autor:
Lynne Strasfeld, Marcie L. Riches
Publikováno v:
Blood and Marrow Transplant Handbook ISBN: 9783030536251
Infection remains an important cause of non-relapse mortality in hematopoietic cell transplant (HCT) recipients. Specific risk for infection is related to prior exposure history (e.g., relapse of latent infection), intensity of the conditioning regim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c711879418c4cb787916b49bf2c45598
https://doi.org/10.1007/978-3-030-53626-8_10
https://doi.org/10.1007/978-3-030-53626-8_10